SCHEMBL13615689

SCHEMBL13615689

c1ccc2c(c1)c1ccccc1n2-c1ccc(-c2c3ccc(-n4c5ccccc5c5ccccc54)cc3c(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)c3ccc(-n4c5ccccc5c5ccccc54)cc23)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.53
KDM4E B2RXH2 1/20 0.53
ATM Q13315 1/20 0.53
KMT2A Q03164 2/20 0.41
HDAC4 P56524 1/20 0.40
EDNRA P25101 2/20 0.37
EDNRB P24530 1/20 0.37
PTPN1 P18031 2/20 0.35
IL1R1 P14778 1/20 0.34
ALDH1A1 P00352 2/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
GPR3 P46089 1/20 0.33
POLB P06746 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
F2 P00734 1/20 0.32
F10 P00742 1/20 0.32
PRSS1 P07477 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11910842 0.93 L3MBTL1 (0.50) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL13319694 0.93 L3MBTL1 (0.50) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL13427964 0.93 L3MBTL1 (0.50) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL1925373 0.93 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL12571778 0.93 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL12928330 0.93 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL13428282 0.93 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL13777108 0.92 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL13777106 0.92 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL275300 0.91 L3MBTL1 (0.64) L3MBTL1KDM4EATMKMT2AHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed
EP-2103666-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-09-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, ORMDL3, CHRM2 L3MBTL1 283/4885KDM4E 3872/4885ATM 4684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.